Search results for "antibody"

Article Affinity Chromatography Handbook: Vol. 1 Antibodies
The purpose of this handbook is to present the most effective and most frequently used strategies for sample preparation and purification of the many different forms of antibodies and antibody fragmen…

Article Antibody Purification Handbook
The purpose of this handbook is to present the most effective and most frequently used strategies for sample preparation and purification of the many different forms of antibodies and antibody fragmen…

Webcast Biotech Makers: Solving challenges in process development of a diversifying antibody pipeline
In this virtual workshop you will hear from scientists from Cytiva and a biopharmaceutical company, who will provide some insight into new purification strategies for these antibody modalities. Thi…

Article Antibody purification quiz
Test your knowledge and gain insights in the purification of antibody variants – bsAbs, Fab, dAbs.

Article Antibody Production Workflow
Explore the workflow here >> Antibody-based therapies have evolved beyond monoclonal antibodies (mAbs) to include bispecific antibodies, antibody fragments, antibody-drug conjugates (ADCs), and m…

Article Advancements in Antibody Purification
Join us on November 19, 2020 to learn from industry experts in a panel discussion on recent advancements and the future of antibody purification.

Article Platform for Purification of VHH-type Antibody Fragments
Click here to read this poster >> Protein A affinity chromatography resins have been used to purify monoclonal antibodies (mAbs) by the bioprocess industry at all scales for a long time. Howev…

Article Monoclonal Antibodies Key to Unlocking the Biosimilars Market
This growth in large part is due to the fact that numerous monoclonal antibody (mAb) biosimilars are expected to be launched in the next few years as patents on key drugs, such as infliximab (Remicade…

Article Optimizing KiH bispecific antibody chromatography steps
Bispecific antibodies (bsAbs) are a promising class of therapeutic agents due to their ability to bind to two different types of antigens or two different epitopes on the same antigen. This a…

Article Downstream Process Developers: What are Your Antibody Processing Challenges?
Let's work together to accelerate antibody downstream process development! Complete the survey

Previous PageNext Page